We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.43B
AUM Growth
+$140M
Cap. Flow
+$62.6M
Cap. Flow %
4.36%
Top 10 Hldgs %
17.76%
Holding
218
New
47
Increased
72
Reduced
39
Closed
34

Top Buys

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$20.7M
2
TLIS
Talis Biomedical Corporation Common Stock
TLIS
+$18.3M
3
KALV
KalVista Pharmaceuticals
KALV
+$15.6M
4
TIL icon
Instil Bio
TIL
+$14.1M
5
XOM icon
ExxonMobil
XOM
+$13.2M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$25.2M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$23.6M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$13.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$13.5M
5
CZR icon
Caesars Entertainment
CZR
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.74%
2 Technology 10.12%
3 Industrials 8.37%
4 Financials 7.73%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEEV icon
26
Veeva Systems
VEEV
$37.4B
$18.4M 1.28%
70,464
+15,404
+28% +$4.29M
PODD icon
27
Insulet
PODD
$9.79B
$18.2M 1.27%
69,653
+21,958
+46% +$5.88M
LSCC icon
28
Lattice Semiconductor
LSCC
$18.5B
$18M 1.25%
399,469
+6,763
+2% +$300K
TFII icon
29
TFI International
TFII
$11.5B
$17.9M 1.25%
239,835
+11,681
+5% +$794K
CELL
30
DELISTED
PhenomeX Inc. Common Stock
CELL
$16.7M 1.17%
333,334
+155,610
+88% +$10.6M
BAC icon
31
Bank of America
BAC
$442B
$16.3M 1.14%
421,491
+107,063
+34% +$3.69M
TXG icon
32
10x Genomics
TXG
$6.61B
$15.6M 1.09%
86,395
+15,480
+22% +$2.67M
KALV
33
DELISTED
KalVista Pharmaceuticals
KALV
$15.3M 1.06%
+594,130
New +$15.6M
MASS icon
34
908 Devices
MASS
$364M
$15M 1.05%
309,634
+216,039
+231% +$12.3M
CZR icon
35
Caesars Entertainment
CZR
$6.14B
$15M 1.04%
171,025
-124,827
-42% -$10.5M
GTLS
36
DELISTED
Chart Industries
GTLS
$14.8M 1.03%
103,890
+52,078
+101% +$7.35M
WSC icon
37
WillScot Mobile Mini Holdings
WSC
$4.41B
$14.5M 1.01%
523,812
+100,334
+24% +$2.63M
SEER icon
38
Seer Inc
SEER
$120M
$14.5M 1.01%
289,989
+201,011
+226% +$11.8M
TRIL
39
DELISTED
Trillium Therapeutics Inc.
TRIL
$14.5M 1.01%
1,346,753
+579,369
+75% +$7.17M
WAL icon
40
Western Alliance Bancorporation
WAL
$8.87B
$14.3M 1%
151,905
+62,237
+69% +$5.15M
JBLU icon
41
JetBlue
JBLU
$2.29B
$14.2M 0.99%
698,642
+111,130
+19% +$1.93M
TLIS
42
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$14.2M 0.99%
+73,427
New +$18.3M
XOM icon
43
ExxonMobil
XOM
$634B
$14M 0.98%
+250,963
New +$13.2M
TIL icon
44
Instil Bio
TIL
$50.3M
$13.8M 0.96%
+27,479
New +$14.1M
CALY
45
Callaway Golf Company
CALY
$3.14B
$13.4M 0.93%
500,964
+35,649
+8% +$1.01M
LVTX
46
DELISTED
LAVA Therapeutics
LVTX
$12.4M 0.86%
+814,840
New +$11.2M
KTB icon
47
Kontoor Brands
KTB
$4.26B
$12M 0.84%
248,202
-42,010
-14% -$1.88M
ARES icon
48
Ares Management
ARES
$30.9B
$11.2M 0.78%
200,000
– –
CHGG icon
49
Chegg
CHGG
$102M
$11.2M 0.78%
130,711
+27,052
+26% +$2.58M
ESTC icon
50
Elastic
ESTC
$7.81B
$11.1M 0.77%
99,667
-3,413
-3% -$485K
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Nicholas Investment Partners held 218 positions worth $1.43B, up 11% from $1.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $62.6M of net new capital in Q1 2021, opening 47 new positions and adding to 72 existing holdings. Its largest new stake was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Caesars Entertainment, an estimated $10.5M trimmed.

  • Nicholas Investment Partners's largest Q1 2021 buy was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.
  • Nicholas Investment Partners added most to 908 Devices in Q1 2021, an estimated $12.3M increase.
  • Nicholas Investment Partners's biggest Q1 2021 reduction was Caesars Entertainment, cutting an estimated $10.5M.
  • Nicholas Investment Partners fully exited Teladoc Health in Q1 2021, selling an estimated $25.2M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.43B portfolio in Q1 2021.
  • Nicholas Investment Partners opened 47 new positions and closed 34 in Q1 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.43B.

Based on Nicholas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.